News Search Results
Feb 19, 2026, 07:19 ET BPC Instruments secures order for BPC Blue system from global testing and certification group
(publ)BPC Instruments is a Swedish technology company developing analytical instruments for renewable bioenergy and environmental biotechnology, including biogas and biodegradability testing. The systems enable advanced testing with higher accuracy and consistency, while reducing the time
More news about: BPC Instruments AB
Feb 19, 2026, 06:15 ET Epson Robots to Exhibit at DesignCon, APEX and MAX in Early 2026
of experience, Epson Robots delivers robots for precision assembly and material handling applications in the aerospace, appliance, automotive, biotechnology, consumer product, electronics, food processing, medical device, pharmaceutical, plastics, semiconductor, and telecommunication industries. For
More news about: Epson America, Inc.
Feb 19, 2026, 03:38 ET Biodegradable Packaging Market to Reach USD 24.2B by 2036 (6.1% CAGR) | PLA Leads (41%) and Food Packaging Tops Demand (40%) | Growth Hotspots: China, India & Germany
that combine different performance characteristics (e.g., PBAT toughness with PLA rigidity). The report also notes growing acquisition interest in biotechnology startups to access microbial fermentation IP for PHA production, and increased collaboration with major CPG brands to pilot closed-loop composting
More news about: Future Market Insights
Feb 18, 2026, 20:47 ET NASDAQ: QURE: Kessler Topaz Meltzer & Check, LLP Files a Securities Fraud Class Action Lawsuit Against uniQure N.V.
speak with an attorney.UNIQURE N.V. CLASS ACTION LAWSUIT - COMPLAINT ALLEGATION SUMMARY: uniQure is a biotechnology company developing gene therapies for rare diseases, including Huntington's disease (HD). uniQure's leading drug candidate is AMT-130, a novel
More news about: Kessler Topaz Meltzer & Check, LLP
Feb 18, 2026, 16:43 ET RGNX Stockholder Alert: Robbins LLP Remind Investors of the Class Action Lawsuit Against REGENXBIO, Inc.
purchased or otherwise acquired REGENXBIO, Inc. (NASDAQ: RGNX) securities between February 9, 2022 and January 27, 2026. REGENXBIO is a clinical-stage biotechnology company providing gene therapies that deliver functional genes to cells with genetic defects in the United States.
More news about: Robbins LLP
Feb 18, 2026, 14:30 ET Human Longevity Launches Personal AI-Powered Longevity App
testing to continuous, personalized health risk management."About Human LongevityFounded in 2013, Human Longevity, Inc. is a biotechnology company at the forefront of integrating genomics, artificial intelligence, and multimodal diagnostics to extend human healthspan. Through its flagship
More news about: Human Longevity, Inc.
Feb 18, 2026, 13:45 ET Draper and the Northeast Microelectronics Coalition (NEMC) Announce Chip Design and Packaging Services to Accelerate Technology Commercialization
meet our customers' requirements. These efforts focus on four critical mission areas: Strategic Systems, Space Systems, Electronic Systems, and Biotechnology Systems. To extend our legacy into the future, the
More news about: Draper Laboratory
Feb 18, 2026, 12:00 ET Lifespan Vision Ventures Co-Leads Sift Biosciences' $3.7M Pre-Seed Financing
Directors. About Lifespan Vision Ventures Lifespan Vision Ventures is a global venture capital firm investing in early-stage biotechnology companies developing breakthrough technologies to prevent and treat age-related diseases. The firm partners with visionary founders advancing science-driven
More news about: LifeSpan Vision Ventures
Feb 18, 2026, 12:00 ET Lifespan Vision Ventures Co-Leads Sift Biosciences' $3.7M Pre-Seed Financing
Directors. About Lifespan Vision Ventures Lifespan Vision Ventures is a global venture capital firm investing in early-stage biotechnology companies developing breakthrough technologies to prevent and treat age-related diseases. The firm partners with visionary founders advancing science-driven
More news about: LifeSpan Vision Ventures
Feb 18, 2026, 11:46 ET Hydrophobic Interaction Chromatography Market to Reach $952.9 Million, Globally, by 2033 at 7.5% CAGR: Allied Market Research
during the forecast period. This is attributed to growing demand for high-quality chromatography products, particularly in biopharmaceuticals and biotechnology industries. The increasing use of hydrophobic interaction chromatography for the purification of monoclonal antibodies, therapeutic proteins, and
More news about: Allied Market Research
Feb 18, 2026, 11:16 ET Astaxanthin Market to Reach $1.6 Billion, Globally, by 2033 at 8.1% CAGR: Allied Market Research
rising health awareness, and growing demand for nutraceuticals and cosmetics in countries such as China, Japan, and India. Increasing investments in biotechnology and expanding middle-class population with higher disposable income further support regional growth.For Purchase Related Queries/Enquiry
More news about: Allied Market Research
Feb 18, 2026, 11:01 ET Egg White Substitute Market to Reach US$ 2.3 Billion by 2033 as Vegan & Functional Food Trends Drive Growth As per Persistence Market Research
Market by Product Type (Liquid Egg Whites, Liquid Egg Yolks, Liquid Whole Eggs), Source (Cage-free, Conventional), Application (Food Industry, Biotechnology, Cosmetic Industry), and Regional Analysis for 2025 - 2032About Persistence Market Research:At Persistence Market Research,
More news about: Persistence Market Research Pvt. Ltd.
Feb 18, 2026, 09:05 ET NeuroSense Announces Statistically Significant 65% Reduction in Risk of Death and Greater than 14-Month Median Survival Benefit with PrimeC in ALS
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-stage clinical biotechnology company focused on developing disease-modifying treatments for neurodegenerative diseases, today announced the availability of additional long-term
More news about: NeuroSense
Feb 18, 2026, 09:00 ET GMP Labeling Partners with Loftware for Digital Label Solutions
integrate physical labels, label printers, and integrated software, addressing the evolving regulatory needs of medical device, pharmaceutical, and biotechnology industries.
More news about: GMP Labeling Inc.
Feb 18, 2026, 09:00 ET ICON plc Faces Investigation After Internal Probe Reveals Multi-Year Revenue Overstatement
world's largest contract research organizations, providing outsourced drug development and clinical trial management services to pharmaceutical and biotechnology companies. The CRO industry relies on long-term service contracts that typically span multiple years, making accurate revenue recognition a critical
More news about: Levi & Korsinsky, LLP
Feb 18, 2026, 09:00 ET Medpace Holdings Under Investigation After Book-to-Bill Miss Exposes Cancellation Surge and Pipeline Fragility
research organizations (CROs) in the clinical-trial industry, providing Phase I through Phase IV drug development services to pharmaceutical and biotechnology companies worldwide. In the CRO sector, the book-to-bill ratio serves as the primary forward-looking indicator of business health. Because CRO revenues
More news about: Levi & Korsinsky, LLP
Feb 18, 2026, 08:54 ET Iaso Therapeutics to Showcase Novel mQβ Vaccine Platform at 2026 World Vaccine Congress
EAST LANSING, Mich., Feb. 18, 2026 /PRNewswire/ -- Iaso Therapeutics, Inc., a biotechnology company redefining infectious disease prevention with its novel synthetic vaccine platform, today announced that it will present at the 2026 World
More news about: Iaso Therapeutics, Inc.
Feb 18, 2026, 08:50 ET Draper Achieves Sustained Recirculation of Immune Cells in a Microphysiological System (MPS)
meet our customers' requirements. These efforts focus on four critical mission areas: Strategic Systems, Space Systems, Electronic Systems, and Biotechnology Systems. To extend our legacy into the future, the
More news about: Draper Laboratory
Feb 18, 2026, 08:35 ET Mecademic Secures Strategic Funding to Drive Global Expansion
next growth phase."Demand for Mecademic's micro-automation solutions is rising in sectors like electronics, optics, medical devices, and biotechnology. Its ultra-compact robotic arms allow manufacturers and labs to integrate high-speed, precise automation into confined spaces where traditional
More news about: Mecademic Industrial Robotics
Feb 18, 2026, 08:32 ET Jeonbuk National University Researchers Develop an Innovative Prussian-Blue Based Electrode for Effective and Efficient Cesium Removal
increasing system complexity and operational costs.A research team led by Professor Jum Suk Jang from the Department of Integrative Environmental Biotechnology, College of Environmental and Bioresource Sciences at Jeonbuk National University, South Korea, developed an innovative method for fabricating PB
More news about: Jeonbuk National University
Feb 18, 2026, 08:30 ET E-Biotech® Launches Patent-Pending AI Regulatory Intelligence Infrastructure for Pharmaceutical and GMP Compliance
Regulatory and GMP operations across pharmaceutical and biotechnology organizations remain fragmented across siloed software systems, static documentation tools, and manually intensive compliance workflows. While enterprise
More news about: E-BIOTECH Inc.
Feb 18, 2026, 08:24 ET Renowned Filmmaker and Creative Director Dr. Bob Gordon Joins Immorta Bio Strategic Advisory Board
MIAMI, Feb. 18, 2026 /PRNewswire/ -- Immorta Bio Inc., a pioneering longevity biotechnology company dedicated to Treating Diseases of Aging and Treating Aging as Disease™, today announced that acclaimed filmmaker and creative director
More news about: Immorta Bio Inc.
Feb 18, 2026, 08:23 ET BiomEdit Initiates Final Field Safety Trial for Non-Antibiotic Poultry Biologic, Advancing Toward USDA Conditional Licensure
GREENFIELD, Ind., Feb. 18, 2026 /PRNewswire/ -- BiomEdit, a pioneering animal health biotechnology company, today announced the initiation of the pivotal field safety trial for its lead candidate, BE-101, a non-antibiotic poultry biologic for
More news about: BiomEdit
Feb 18, 2026, 08:15 ET RoviSys Advances Regulated Industry Facilities Strategy, Names Chris Kulbago Director
discrete manufacturing automation solutions, is pleased to reaffirm its expanded facilities systems integration capabilities for pharmaceutical, biotechnology, and medical device manufacturers. As regulatory expectations increase and facilities become more complex, manufacturers require reliable and integrated
More news about: RoviSys
Feb 18, 2026, 08:00 ET Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-based Agricultural Products
BOSTON, Feb. 18, 2026 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA, "Ginkgo") and Invaio Sciences, an agricultural biotechnology company leading in nature-positive crop protection solutions, today announced a collaboration to develop strains that can efficiently manufacture
More news about: Ginkgo Bioworks